Institutional investors purchased a net $1.7 million shares of NUVA during the quarter ended March 2017 and now own 104.89% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
VIKING GLOBAL INVESTORS LP Bought 536.8 Thousand shares of NuVasive Inc
OPPENHEIMERFUNDS, INC. Bought 433.5 Thousand shares of NuVasive Inc
VICTORY CAPITAL MANAGEMENT, INC. Bought 296.6 Thousand shares of NuVasive Inc